Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== circ_0055412 ====== Recent evidence has suggested that [[circular RNA]]s (circRNAs) are associated with the pathological processes in [[glioma]]. Zhou et al. aimed to investigate the function and mechanism of circ_CAPG (circ_0055412) in [[glioma]]. Firstly, circ_0055412 expression was examined through [[Real-time polymerase chain reaction]] analysis. Loss-of-function assays and animal experiments were implemented to evaluate the role of circ_0055412 on [[cisplatin resistance]] of glioma cells. Moreover, mechanism assays were done to probe into the regulatory mechanism of circ_0055412 in glioma cells. Circ_0055412 was found to be notably upregulated in glioma cells. Moreover, depletion of circ_0055412 enhanced cisplatin sensitivity of glioma cells in vitro and in vivo. Moreover, circ_0055412 recruited eukaryotic translation initiation factor 4A3 (EIF4A3) protein to stabilize capping actin protein, gelsolin-like (CAPG) mRNA. Furthermore, circ_0055412 served as a sponge for microRNA-330-3p (miR-330-3p) and regulated nuclear factor of activated T cells 3 (NFATC3) expression to activate the transcription of catenin beta 1 (CTNNB1), thus participating in the activation of the Wnt/β-catenin signaling pathway. Circ_0055412 contributed to cisplatin resistance of glioma cells via stabilizing CAPG mRNA and modulating the [[Wnt]]/[[β-catenin]] [[signaling pathway]]. This finding might provide novel information for [[glioma treatment]] ((Zhou Q, Fu Q, Shaya M, Kugeluke Y, Li S, Dilimulati Y. Knockdown of circ_0055412 promotes [[cisplatin]] sensitivity of glioma cells through modulation of CAPG and Wnt/β-catenin signaling pathway. CNS Neurosci Ther. 2022 Mar 25. doi: 10.1111/cns.13820. Epub ahead of print. PMID: 35332692.)). circ_0055412.txt Last modified: 2024/06/07 02:55by 127.0.0.1